ArticleGut1997
Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases.
Article in Gut, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 36 citations in OpenAlex.
- Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up.World journal of gastroenterology · 2017Article
- The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.BMC cancer · 2016Article
- Increased levels of sperm protein 17 mRNA and circulating antibodies in periampullary carcinoma patients.International journal of clinical oncology · 2015Article
- Adenocarcinoma of the ampulla of Vater: predictors of survival and recurrence after curative radical resection.Korean journal of hepato-biliary-pancreatic surgery · 2011Article
- Markers of bile duct tumors.World journal of gastrointestinal oncology · 2011Article
- Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2007Article
- Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma.World journal of surgery · 2005Article
- Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.Journal of clinical pathology · 2005Article
- Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.World journal of gastroenterology · 2004Article
- Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis.Gut · 2000Article
- Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.Annals of surgery · 1999Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSome adjuvant or neoadjuvant therapy could be important for patients operated on for tumours of the ampulla of Vater, especially for those having a higher risk of recurrence.
aimTo evaluate prognostic factors after curative surgery based on a series of 45 cases of malignant tumours of the Oddi sphincter. PATIENTS: From 1970 to 1992, a curative resection was performed in 45 patients (age 62.8 (SD 10.1) years) with adenocarcinoma of the ampulla. Surgical procedures included pancreatoduodenectomy (n = 42) and resection of the ampulla (n = 3). Actuarial survival was 44 (SD 9)% at five years.
methodsVarious prognostic variables were studied: clinical manifestations, macroscopic aspect, differentiation, noninvasive adenomatous component, mucin histochemistry, immunohistochemistry (CEA, CA19.9, p53, Ki67), and accepted classifications (Blumgart and Kennedy, Martin, Yamaguchi and Enjoji, Talbot et al, pTNM).
resultsVariables with prognostic power, in order of importance were: Classification of Talbot et al; CA19.9; pTNM; sialomucins; classification of Yamaguchi and Ejoji; Martin classification; sulphomucins; non-invasive adenomatous component (positive > negative); jaundice; tumour localisation.
conclusionsThis series confirmed the prognostic power of former classifications and showed the prognostic power of other variables (mucin, non-invasive adenomatous component, CA19.9).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.